Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
23,865 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Nebius Group flags a fragile link between borrowing costs and AI investment. The remarks underscore how rate moves fr...
Lenders are adopting ai-powered data remaps builders’ to accelerate land acquisitions and adjust financing terms amid...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...
A multi-decade rally faces a valuation crossroads as the CAPE gauge sits near historic highs. Here’s how years market...
Lowe's 2026 earnings outlook hinges on margin discipline and online growth. This guide breaks down what to watch and ...
A new northwestern mutual 2025 study shows most Americans have no will, with Gen X and Baby Boomers lagging in estate...
A sweeping shift in government-backed tech funding is changing how investors value IBM and Intel. Taxpayers, once dis...
XRP holds firm while BTC and ETH slide, buoyed by steady ETF flows into XRP products and a surge in XRP wallet activi...
Target stock faces a pivotal test as margins and non-merchandise revenue drive valuation. With 2027 upside priced int...
BitGo and Galaxy Digital continue their in-court battle over a failed $1.2 billion merger, with BitGo seeking damages...
Walmart is steering toward higher-margin online services and automation as it grows. The big question for investors i...